Evidence map›Paper›PMID 35179207›Full record

ArticleThe Biochemical journal2022

Sequence and structural variations determining the recruitment of WNK kinases to the KLHL3 E3 ligase.

Zhuoyao Chen, Jinwei Zhang, Adrián R Murillo-de-Ozores, María Castañeda-Bueno, Francesca D'Amico, Raphael Heilig, Charlotte E Manning, Fiona J Sorrell, Vincenzo D'Angiolella, Roman Fischer and 4 more

Open access · hybridAbstract read
In one paragraph

Article in The Biochemical journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. UBR5 is a novel regulator of WNK1 stability.American journal of physiology. Cell physiology · 2022
    Article
  3. WNK1 in Malignant Behaviors: A Potential Target for Cancer?Frontiers in cell and developmental biology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 3 countries.

Zhuoyao ChenCentre for Medicines Discovery, New Biochemistry Building, University of Oxford, South Parks Road, Oxford OX1 3QU, U.K.
Jinwei ZhangMRC Protein Phosphorylation and Ubiquitylation Unit, College of Life Sciences, University of Dundee, Dow Street, Dundee DD15EH, Scotland, U.K.
Adrián R Murillo-de-OzoresDepartment of Nephrology and Mineral Metabolism, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Tlalpan, Mexico City, Mexico.
María Castañeda-BuenoDepartment of Nephrology and Mineral Metabolism, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Tlalpan, Mexico City, Mexico.
Francesca D'AmicoOncode Institute and Department of Cell and Chemical Biology, Leiden University Medical Center (LUMC), Einthovenweg 20, 2333, ZC, Leiden, The Netherlands.
Raphael HeiligTarget Discovery Institute, Nuffield Department of Medicine, University of Oxford, Roosevelt Drive, Oxford OX3 7FZ, U.K.
Charlotte E ManningCentre for Medicines Discovery, New Biochemistry Building, University of Oxford, South Parks Road, Oxford OX1 3QU, U.K.
Fiona J SorrellCentre for Medicines Discovery, New Biochemistry Building, University of Oxford, South Parks Road, Oxford OX1 3QU, U.K.
Vincenzo D'AngiolellaDepartment of Oncology, Cancer Research U.K.. and Medical Research Council Institute for Radiation Oncology, University of Oxford, Roosevelt Drive, Oxford OX3 7DQ, U.K.
Roman FischerTarget Discovery Institute, Nuffield Department of Medicine, University of Oxford, Roosevelt Drive, Oxford OX3 7FZ, U.K.
Monique P C MulderOncode Institute and Department of Cell and Chemical Biology, Leiden University Medical Center (LUMC), Einthovenweg 20, 2333, ZC, Leiden, The Netherlands.
Gerardo GambaDepartment of Nephrology and Mineral Metabolism, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Tlalpan, Mexico City, Mexico.
Dario R AlessiMRC Protein Phosphorylation and Ubiquitylation Unit, College of Life Sciences, University of Dundee, Dow Street, Dundee DD15EH, Scotland, U.K.ORCID 0000-0002-2140-9185
Alex N BullockCentre for Medicines Discovery, New Biochemistry Building, University of Oxford, South Parks Road, Oxford OX1 3QU, U.K.ORCID 0000-0001-6757-0436
University of Oxford · GBInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán · MXJenner Institute · GBLeiden University Medical Center · NLMRC Protein Phosphorylation and Ubiquitylation Unit · GBCRUK/MRC Oxford Institute for Radiation Oncology · GB

Funding

Medical Research Council MC_UU_00001/7Medical Research Council MC_UU_00018/1Medical Research Council MC_UU_12016/2Medical Research Council MR/X006980/1
6 · The paper itself

Abstract

The BTB-Kelch protein KLHL3 is a Cullin3-dependent E3 ligase that mediates the ubiquitin-dependent degradation of kinases WNK1-4 to control blood pressure and cell volume. A crystal structure of KLHL3 has defined its binding to an acidic degron motif containing a PXXP sequence that is strictly conserved in WNK1, WNK2 and WNK4. Mutations in the second proline abrograte the interaction causing the hypertension syndrome pseudohypoaldosteronism type II. WNK3 shows a diverged degron motif containing four amino acid substitutions that remove the PXXP motif raising questions as to the mechanism of its binding. To understand this atypical interaction, we determined the crystal structure of the KLHL3 Kelch domain in complex with a WNK3 peptide. The electron density enabled the complete 11-mer WNK-family degron motif to be traced for the first time revealing several conserved features not captured in previous work, including additional salt bridge and hydrogen bond interactions. Overall, the WNK3 peptide adopted a conserved binding pose except for a subtle shift to accommodate bulkier amino acid substitutions at the binding interface. At the centre, the second proline was substituted by WNK3 Thr541, providing a unique phosphorylatable residue among the WNK-family degrons. Fluorescence polarisation and structural modelling experiments revealed that its phosphorylation would abrogate the KLHL3 interaction similarly to hypertension-causing mutations. Together, these data reveal how the KLHL3 Kelch domain can accommodate the binding of multiple WNK isoforms and highlight a potential regulatory mechanism for the recruitment of WNK3.

Indexed as

HypertensionUbiquitin-Protein LigasesAdaptor Proteins, Signal TransducingHumansMicrofilament ProteinsPhosphorylationProlineProtein Serine-Threonine KinasesUbiquitinAdaptor Proteins, Signal TransducingKLHL3 protein, humanMicrofilament ProteinsProlineProtein Serine-Threonine KinasesUbiquitinUbiquitin-Protein LigasesWNK2 protein, humancrystallographydegronhypertensionmutationprotein-serine-threonine kinasesubiquitin ligases

Identifiers

PMID35179207
PMCPMC9022995
OpenAlexW4220844056

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.